Evidence map›Paper›PMID 41182197›Full record

ArticleCurrent protocols2025

Adaptable Immunofluorescence Protocol for Muscle Fiber Typing in FFPE Human and Mouse Skeletal Muscle and Intact Mouse Hindlimbs.

Connor Thomas, Lainey M Hibbard, Kenneth E White, Steven S Welc

Abstract read
In one paragraph

Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Connor ThomasDepartment of Anatomy, Cell Biology, & Physiology, Indiana University School of Medicine, Indianapolis, Indianapolis.
Lainey M HibbardDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indianapolis.
Kenneth E WhiteDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indianapolis.
Steven S WelcDepartment of Anatomy, Cell Biology, & Physiology, Indiana University School of Medicine, Indianapolis, Indianapolis.ORCID https://orcid.org/0000-0002-2353-0325

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle fiber type composition affects muscle function, metabolism, and disease vulnerability. In addition, muscle fiber type analysis informs disease diagnosis and underlying pathophysiology. Multiple methodologies can be used to assess muscle fiber type; however, immunofluorescence (IF) for myosin heavy chain (MyHC) isoforms is the most widely used modern approach due to its relative ease, time-effectiveness, single-cell resolution, and capacity to preserve spatial positioning within the native tissue architecture. Here, we present a protocol for IF for MyHC labeling on formalin-fixed paraffin-embedded (FFPE) mouse and human muscle sections. We then describe a modified procedure for fiber type analysis of the intact mouse lower hindlimb, enabling high-throughput muscle composition and morphological analysis across distinct muscles on a single tissue section. Traditionally, IF labeling for MyHC isoforms required fresh tissue flash-frozen in liquid nitrogen-cooled isopentane, which, while effective, presents challenges for sample processing and preservation, long-term storage, transport, and biosafety. Comparatively, embedding tissue in paraffin after formalin fixation streamlines clinical workflows, preserves morphology, improves long-term sample stability, and simplifies sample storage and transport. Furthermore, FFPE effectively inactivates most infectious agents, which can be retained in frozen sections. Thus, FFPE samples are typically safe for standard laboratory handling and are not classified as biohazardous. This approach can be adapted for use with a range of downstream applications, including integration of fiber type analysis with emerging next-generation techniques that favor FFPE samples. In sum, this method offers a robust alternative to traditional fresh-frozen protocols and allows for simultaneous fiber type analysis across multiple muscle tissues. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol: Multiplex Immunofluorescence for MyHC Labeling in FFPE Skeletal Muscle Tissues Alternate Protocol 1: Immunofluorescence for MyHC 2x Labeling in FFPE Skeletal Muscle Tissues Alternate Protocol 2: Multiplex Immunofluorescence for MyHC Labeling in FFPE Whole Hindlimb Sections.

Indexed as

Fluorescent Antibody TechniqueHindlimbMuscle Fibers, SkeletalMuscle, SkeletalAnimalsFormaldehydeHumansMiceMyosin Heavy ChainsParaffin EmbeddingTissue FixationFormaldehydeMyosin Heavy Chainsformalin‐fixed paraffin‐embeddedimmunofluorescencemyosin heavy chainskeletal muscle fiber type

Identifiers

PMID41182197
PMCPMC12582162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.